DNMR - Danimer Scientific reports Q4 results

Danimer Scientific (DNMR): Q4 GAAP EPS of -$0.26.Revenue of $12.03M (+37.8% Y/Y)At December 31, 2020, total debt outstanding of $56.6M and cash of $377.6M.For FY21, the company anticipates capital expenditures to be in the range of $100 to $125M, primarily to invest in the planned capacity expansions to meet the expected current and long-term demand from its growing customer base.The company expects Adjusted EBITDA and cash flow from operations to benefit in 2021 from operational efficienciesPress Release

For further details see:

Danimer Scientific reports Q4 results